ABT Short Volume
Abbott Laboratories (ABT) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $146.00B, listed on NYSE, employing roughly 114,000 people, carrying a beta of 0.65 to the broader market. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Led by Robert Ford, public since 1980-03-17.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 1.0M
- Total Volume
- 5.6M
- Short %
- 18.41%
- 30-Day Avg Short %
- 32.04%
Showing 30 days of FINRA short volume data for Abbott Laboratories.
Learn how short volume is reported and how to read the data →
Frequently asked ABT short volume questions
- What is the daily ABT short volume?
- As of May 15, 2026, Abbott Laboratories (ABT) short volume is 1.0M shares against 5.6M total reported volume, or 18.41% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is ABT short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does ABT short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.